+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hong Kong Wound Dressing Market Research Report: By Type, Application, End User, Distribution Channel - Industry Analysis and Growth Forecast to 2030

  • ID: 5184631
  • Report
  • June 2020
  • Region: Hong Kong
  • 189 pages
  • Prescient & Strategic Intelligence Private Limited
1 of 4

FEATURED COMPANIES

  • 3M Company
  • BSN medical GmbH
  • ConvaTec Group PLC
  • Medtronic plc
  • Paul Hartmann AG
  • Wayson Medical Co. Ltd.
  • MORE
The Hong Kong wound care market is predicted to reach a value of $80.7 million by 2030, rising from $46.0 million in 2019, progressing at a 5.4% CAGR during the forecast period (2020–2030), as stated by a the publisher report. The key factors leading to the growth of the market are the increasing incidence of traumatic injuries, surging prevalence of diabetes, and rising geriatric population. The market is bifurcated into traditional and advanced, on the basis of type.

Between these two, the advanced bifurcation held the larger revenue share of the market in 2019, as advanced wound care products aid in accelerating the wound healing process and further provide patients with convenience. In addition to this, these wound care products have the advantage of forming part of the natural tissue matrix. The increasing prevalence of chronic diseases across the globe is also driving the demand for advanced wound care products. The bifurcation is further divided into wound therapy devices, wound dressings, and wound care biologics.

In terms of application, the Hong Kong wound care market is categorized into acute wounds an chronic wounds, between which, the chronic wound category held the major share of the market in 2019. The category is further projected to grow at a faster pace during the forecast period, owing to the surging incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers. Chronic wounds need frequent and more-efficient dressing for their management, which is leading to the growth of the market.

The rapidly increasing prevalence of diabetes is also a major factor resulting in the growth of the Hong Kong wound care market. As per the Centre for Health Protection, which is an agency under the Department of Health of Hong Kong, in 2017, diabetes was the major cause of mortality and morbidity in the metropolis. Diabetic patients are highly susceptible to developing wounds, and the wound healing process is further slowed down because of diabetes, which creates high demand for wound care products.

In conclusion, the market is growing due to the increasing prevalence of traumatic injuries and rising incidence of diabetes in Hong Kong.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Company
  • BSN medical GmbH
  • ConvaTec Group PLC
  • Medtronic plc
  • Paul Hartmann AG
  • Wayson Medical Co. Ltd.
  • MORE
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by Application
1.3.3 Market Segmentation by End User
1.3.4 Market Segmentation by Distribution Channel
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.3.6.1 Volume
1.3.6.2 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Split of Primary Research Information
2.2.2 Breakdown of Primary Research Respondents
2.2.2.1 By industry participant
2.2.2.2 By company type
2.2.3 Breakdown of Primary Research by Company and Designation
2.3 Baseline Methodology
2.4 Market Size Estimation
2.5 Data Triangulation
2.6 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Market Definition
4.1.1 By Type
4.1.1.1 Advanced
4.1.1.1.1 Foam
4.1.1.1.2 Hydrocolloid
4.1.1.1.3 Film
4.1.1.1.4 Alginate
4.1.1.1.5 Antimicrobial
4.1.1.1.6 Hydrogel
4.1.1.1.7 Collagen
4.1.1.1.8 Hydrofiber
4.1.1.1.9 Wound contact layer
4.1.1.1.10 Superabsorbent
4.1.1.1.11 NPWT
4.1.1.1.12 Others
4.1.1.2 Traditional
4.1.1.2.1 Bandages
4.1.1.2.2 Gauzes
4.1.1.2.3 Sponges
4.1.1.2.4 Abdominal pads
4.1.1.2.5 Others
4.1.2 By Application
4.1.2.1 Chronic wounds
4.1.2.1.1 DFUs
4.1.2.1.2 VLUs
4.1.2.1.3 Pressure ulcers
4.1.2.1.4 Others
4.1.2.2 Acute wounds
4.1.2.2.1 Surgical and traumatic wounds
4.1.2.2.2 Burns
4.1.3 By End User
4.1.3.1 Hospitals and specialty clinics
4.1.3.1.1 Inpatient settings
4.1.3.1.2 Outpatient settings
4.1.3.2 Home healthcare
4.1.3.3 Long-term care settings
4.1.4 By Distribution Channel
4.1.4.1 Pharmacies
4.1.4.2 Online channels
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Shift in preference from traditional products to advanced therapies
4.2.2 Drivers
4.2.2.1 Growing geriatric population
4.2.2.2 Increasing prevalence of diabetes
4.2.2.3 High incidence of traumatic injuries
4.2.2.4 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 High cost of advanced wound dressing products
4.2.3.2 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Improving economy and increasing health expenditure
4.2.4.2 Ineffectiveness of traditional wound dressings in acute wound management
4.3 Impact of COVID-19
4.4 Porter’s Five Forces Analysis
4.5 Regulatory Overview
4.6 Wound Dressing Product Pricing

Chapter 5. Epidemiology of Wounds in Hong Kong
5.1 Total Incidence of Wounds
5.2 Incidence of Wounds, By Type
5.2.1 Incidence of Acute Wounds, by type
5.2.2 Incidence of Chronic Wounds, by Type

Chapter 6. Hong Kong Market Size and Forecast
6.1 By Type
6.1.1 Advanced Wound Dressing Market, by Type
6.1.1.1 Foam dressing market
6.1.1.1.1 By hospital type
6.1.1.1.2 By prescription mode
6.1.1.2 Hydrocolloid dressing market
6.1.1.2.1 By hospital type
6.1.1.2.2 By prescription mode
6.1.1.3 Film dressing market
6.1.1.3.1 By hospital type
6.1.1.3.2 By prescription mode
6.1.1.4 Alginate dressing market
6.1.1.4.1 By hospital type
6.1.1.4.2 By prescription mode
6.1.1.5 Antimicrobial dressing market
6.1.1.5.1 By hospital type
6.1.1.5.2 By prescription mode
6.1.1.6 Hydrogel dressing market
6.1.1.6.1 By hospital type
6.1.1.6.2 By prescription mode
6.1.1.7 Collagen dressing market
6.1.1.7.1 By hospital type
6.1.1.7.2 By prescription mode
6.1.1.8 Hydrofiber dressing market
6.1.1.8.1 By hospital type
6.1.1.8.2 By prescription mode
6.1.1.9 Wound contact layers dressing market
6.1.1.9.1 By hospital type
6.1.1.9.2 By prescription mode
6.1.1.10 Superabsorbent dressing market
6.1.1.10.1 By hospital type
6.1.1.10.2 By prescription mode
6.1.1.11 NPWT dressing market
6.1.1.11.1 By hospital type
6.1.1.11.2 By prescription mode
6.1.2 Traditional Wound Dressing Market, by Type
6.2 By Application
6.2.1 Wound Dressing Market for Chronic Wounds, by Type
6.2.2 Wound Dressing Market for Acute Wounds, by Type
6.3 By End User
6.3.1 Wound Dressing Market in Hospitals and Specialty Clinics, by Type
6.4 By Distribution Channel

Chapter 7. Competitive Landscape
7.1 Revenue Share Analysis of Major Companies
7.1.1 3M Company
7.1.2 ConvaTec Group Plc
7.1.3 Coloplast A/S
7.1.4 PAUL HARTMANN Asia-Pacific Ltd.
7.1.5 Winner Medical Co. Ltd.
7.1.6 Mölnlycke Health Care AB
7.1.7 Smith & Nephew plc
7.2 Advanced Wound Dressings Usage Share Analysis, By Hospital
7.2.1 Government Hospitals
7.2.1.1 Tuen Mun Hospital (TMH)
7.2.1.2 United Christian Hospital (UCH)
7.2.1.3 Queen Elizabeth Hospital (QEH)
7.2.1.4 Prince of Wales Hospital (PWH)
7.2.1.5 Pamela Youde Nethersole Eastern Hospital (PYNEH)
7.2.1.6 Princess Margaret Hospital (PMH)
7.2.1.7 Queen Mary Hospital (QMH)
7.2.2 Private Hospitals
7.2.2.1 Evangel Hospital
7.2.2.2 Gleneagles Hong Kong Hospital
7.2.2.3 Hong Kong Adventist Hospital
7.2.2.4 Hong Kong Baptist Hospital
7.2.2.5 Hong Kong Sanatorium & Hospital Limited
7.2.2.6 Matilda & War Memorial Hospital
7.2.2.7 Precious Blood Hospital
7.2.2.8 St. Paul's Hospital
7.2.2.9 St. Teresa's Hospital
7.2.2.10 Union Hospital
7.2.2.11 Canossa Hospital
7.3 Strategic Developments of Key Players
7.3.1 Mergers and Acquisitions
7.3.2 Partnerships
7.3.3 Other Developments

Chapter 8. Company Profiles
8.1 Coloplast A/S
8.1.1 Business Overview
8.1.2 Product and Service Offerings
8.1.3 Key Financial Summary
8.2 3M Company
8.2.1 Business Overview
8.2.2 Product and Service Offerings
8.2.3 Key Financial Summary
8.3 Paul Hartmann AG
8.3.1 Business Overview
8.3.2 Product and Service Offerings
8.3.3 Key Financial Summary
8.4 Winner Medical Co. Ltd.
8.4.1 Business Overview
8.4.2 Product and Service Offerings
8.5 Mölnlycke Health Care AB
8.5.1 Business Overview
8.5.2 Product and Service Offerings
8.5.3 Key Financial Summary
8.6 Smith & Nephew PLC
8.6.1 Business Overview
8.6.2 Product and Service Offerings
8.6.3 Key Financial Summary
8.7 ConvaTec Group PLC
8.7.1 Business Overview
8.7.2 Product and Service Offerings
8.7.3 Key Financial Summary
8.8 Allmed Medical Products Co. Ltd.
8.8.1 Business Overview
8.8.2 Product and Service Offerings
8.9 Zhende Medical Co. Ltd.
8.9.1 Business Overview
8.9.2 Product and Service Offerings
8.10 Wayson Medical Co. Ltd.
8.10.1 Business Overview
8.10.2 Product and Service Offerings
8.11 B. Braun Melsungen AG
8.11.1 Business Overview
8.11.2 Product and Service Offerings
8.11.3 Key Financial Summary
8.12 BSN medical GmbH
8.12.1 Business Overview
8.12.2 Product and Service Offerings
8.13 Beiersdorf AG
8.13.1 Business Overview
8.13.2 Product and Service Offerings
8.13.3 Key Financial Summary
8.14 Johnson & Johnson
8.14.1 Business Overview
8.14.2 Product and Service Offerings
8.14.3 Key Financial Summary
8.15 Urgo Medical
8.15.1 Business Overview
8.15.2 Product and Service Offerings
8.16 Cardinal Health Inc.
8.16.1 Business Overview
8.16.2 Product and Service Offerings
8.16.3 Key Financial Summary
8.17 Medtronic plc
8.17.1 Business Overview
8.17.2 Product and Service Offerings
8.17.3 Key Financial Summary
8.18 Integra LifeSciences Holdings Corporation
8.18.1 Business Overview
8.18.2 Product and Service Offerings
8.18.3 Key Financial Summary
8.19 Wright Medical Group N.V.
8.19.1 Business Overview
8.19.2 Product and Service Offerings
8.19.3 Key Financial Summary
8.20 Medela AG
8.20.1 Business Overview
8.20.2 Product and Service Offerings
8.21 Lohmann & Rauscher GmbH & Co. KG
8.21.1 Business Overview
8.21.2 Product and Service Offerings
8.22 Nitto Denko Corporation
8.22.1 Business Overview
8.22.2 Product and Service Offerings
8.22.3 Key Financial Summary
8.23 Weigao Group Co. Ltd.
8.23.1 Business Overview
8.23.2 Product and Service Offerings
8.23.3 Key Financial Summary

Chapter 9. Appendix
9.1 Abbreviations
9.2 Sources and References
9.3 Related Report

List of Tables
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 PRICING OF SOME MAJORLY USED WOUND DRESSING PRODUCTS
TABLE 5 INCIDENCE OF WOUNDS IN HONG KONG (2014-2019)
TABLE 6 INCIDENCE OF WOUNDS IN HONG KONG (2020-2030)
TABLE 7 INCIDENCE OF WOUNDS IN HONG KONG, BY TYPE (2014-2019)
TABLE 8 INCIDENCE OF WOUNDS IN HONG KONG, BY TYPE (2020-2030)
TABLE 9 INCIDENCE OF ACUTE WOUNDS IN HONG KONG, BY TYPE (2014-2019)
TABLE 10 INCIDENCE OF ACUTE WOUNDS IN HONG KONG, BY TYPE (2020-2030)
TABLE 11 INCIDENCE OF CHRONIC WOUNDS IN HONG KONG, BY TYPE (2014-2019)
TABLE 12 INCIDENCE OF CHRONIC WOUNDS IN HONG KONG, BY TYPE (2020-2030)
TABLE 13 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2019)
TABLE 14 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2020-2030)
TABLE 15 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2019)
TABLE 16 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2020-2030)
TABLE 17 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, UNITS (2014-2019)
TABLE 18 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, UNITS (2020-2030)
TABLE 19 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 20 HONG KONG FOAM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 21 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 22 HONG KONG FOAM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 23 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 24 HONG KONG HYDROCOLLOID DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 25 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 26 HONG KONG HYDROCOLLOID DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 27 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 28 HONG KONG FILM DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 29 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 30 HONG KONG FILM DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 31 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 32 HONG KONG ALGINATE DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 33 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 34 HONG KONG ALGINATE DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 35 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 36 HONG KONG ANTIMICROBIAL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 37 HONG KONG ANTIMICROBIALS DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 38 HONG KONG ANTIMICROBIALS DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 39 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 40 HONG KONG HYDROGEL DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 41 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 42 HONG KONG HYDROGEL DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 43 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 44 HONG KONG COLLAGEN DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 45 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 46 HONG KONG COLLAGEN DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 47 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 48 HONG KONG HYDROFIBER DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 49 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 50 HONG KONG HYDROFIBER DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 51 HONG KONG WOUND CONTACT LAYERS DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 52 HONG KONG WOUND CONTACT LAYERS DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 53 HONG KONG WOUND CONTACT LAYERS DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 54 HONG KONG WOUND CONTACT LAYERS DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 55 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 56 HONG KONG SUPERABSORBENT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 57 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 58 HONG KONG SUPERABSORBENT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 59 HONG KONG NPWT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2014-2019)
TABLE 60 HONG KONG NPWT DRESSING MARKET, BY HOSPITAL TYPE, $’000 (2020-2030)
TABLE 61 HONG KONG NPWT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2014-2019)
TABLE 62 HONG KONG NPWT DRESSING MARKET, BY PRESCRIPTION MODE, $’000 (2020-2030)
TABLE 63 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2019)
TABLE 64 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2020-2030)
TABLE 65 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, UNITS (2014-2019)
TABLE 66 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, UNITS (2020-2030)
TABLE 67 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2014-2019)
TABLE 68 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2020-2030)
TABLE 69 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2014-2019)
TABLE 70 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2020-2030)
TABLE 71 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2014-2019)
TABLE 72 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2020-2030)
TABLE 73 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2014-2019)
TABLE 74 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2020-2030)
TABLE 75 HONG KONG WOUND DRESSING MARKET IN HOSPITALS AND SPECIALTY CLINICS, BY TYPE, $’000 (2014-2019)
TABLE 76 HONG KONG WOUND DRESSING MARKET IN HOSPITALS AND SPECIALTY CLINICS, BY TYPE, $’000 (2020-2030)
TABLE 77 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2014-2019)
TABLE 78 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2020-2030)
TABLE 79 3M COMPANY - SHARE BY PRODUCT
TABLE 80 CONVATEC GROUP PLC - SHARE BY PRODUCT
TABLE 81 COLOPLAST A/S - SHARE BY PRODUCT
TABLE 82 PAUL HARTMANN ASIA-PACIFIC LTD. - SHARE BY PRODUCT
TABLE 83 WINNER MEDICAL CO. LTD. - SHARE BY PRODUCT
TABLE 84 MÖLNLYCKE HEALTH CARE AB - SHARE BY PRODUCT
TABLE 85 SMITH & NEPHEW PLC - SHARE BY PRODUCT
TABLE 86 TUEN MUM HOSPITAL - SHARE BY PRODUCT
TABLE 87 UNITED CHRISTIAN HOSPITAL - SHARE BY PRODUCT
TABLE 88 QUEEN ELIZABETH HOSPITAL - SHARE BY PRODUCT
TABLE 89 PRINCE OF WALES HOSPITAL - SHARE BY PRODUCT
TABLE 90 PAMELA YOUNDE NETHERSOLE EASTERN HOSPITAL - SHARE BY PRODUCT
TABLE 91 PRINCESS MARGARET HOSPITAL - SHARE BY PRODUCT
TABLE 92 QUEEN MARY HOSPITAL - SHARE BY PRODUCT
TABLE 93 EVANGEL HOSPITAL - SHARE BY PRODUCT
TABLE 94 GLENEAGLES HONG KONG HOSPITAL - SHARE BY PRODUCT
TABLE 95 HONG KONG ADVENTIST HOSPITAL - SHARE BY PRODUCT
TABLE 96 HONG KONG BAPTIST HOSPITAL - SHARE BY PRODUCT
TABLE 97 HONH KONG SANATORIUM & HOSPITAL LIMITED - SHARE BY PRODUCT
TABLE 98 MATILDA & WAR MEMORIAL HOSPITAL - SHARE BY PRODUCT
TABLE 99 PRECIOUS BLOOD HOSPITAL - SHARE BY PRODUCT
TABLE 100 ST. PAUL’S HOSPITAL - SHARE BY PRODUCT
TABLE 101 ST. TERESA’S HOSPITAL - SHARE BY PRODUCT
TABLE 102 UNION HOSPITAL - SHARE BY PRODUCT
TABLE 103 CANOSSA HOSPITAL - SHARE BY PRODUCT
TABLE 104 COLOPLAST A/S - AT A GLANCE
TABLE 105 COLOPLAST A/S - KEY FINANCIAL SUMMARY
TABLE 106 3M COMPANY - AT A GLANCE
TABLE 107 3M COMPANY - KEY FINANCIAL SUMMARY
TABLE 108 PAUL HARTMANN AG - AT A GLANCE
TABLE 109 PAUL HARTMANN AG - KEY FINANCIAL SUMMARY
TABLE 110 WINNER MEDICAL CO. LTD. - AT A GLANCE
TABLE 111 MÖLNLYCKE HEALTH CARE AB - AT A GLANCE
TABLE 112 MÖLNLYCKE HEALTH CARE AB - KEY FINANCIAL SUMMARY
TABLE 113 SMITH & NEPHEW PLC - AT A GLANCE
TABLE 114 SMITH & NEPHEW PLC - KEY FINANCIAL SUMMARY
TABLE 115 CONVATEC GROUP PLC - AT A GLANCE
TABLE 116 CONVATEC GROUP PLC - KEY FINANCIAL SUMMARY
TABLE 117 ALLMED MEDICAL PRODUCTS CO. LTD. - AT A GLANCE
TABLE 118 ZHENDE MEDICAL CO. LTD. - AT A GLANCE
TABLE 119 WAYSON MEDICAL CO. LTD. - AT A GLANCE
TABLE 120 B. BRAUN MELSUNGEN AG - AT A GLANCE
TABLE 121 B. BRAUN MELSUNGEN AG - KEY FINANCIAL SUMMARY
TABLE 122 BSN MEDICAL GMBH - AT A GLANCE
TABLE 123 BEIERSDORF AG - AT A GLANCE
TABLE 124 BEIERSDORF AG - KEY FINANCIAL SUMMARY
TABLE 125 JOHNSON & JOHNSON - AT A GLANCE
TABLE 126 JOHNSON & JOHNSON - KEY FINANCIAL SUMMARY
TABLE 127 URGO MEDICAL - AT A GLANCE
TABLE 128 CARDINAL HEALTH INC. - AT A GLANCE
TABLE 129 CARDINAL HEALTH INC. - KEY FINANCIAL SUMMARY
TABLE 130 MEDTRONIC PLC - AT A GLANCE
TABLE 131 MEDTRONIC PLC - KEY FINANCIAL SUMMARY
TABLE 132 INTEGRA LIFESCIENCES HOLDINGS CORPORATION - AT A GLANCE
TABLE 133 INTEGRA LIFESCIENCES HOLDINGS CORPORATION - KEY FINANCIAL SUMMARY
TABLE 134 WRIGHT MEDICAL GROUP N.V. - AT A GLANCE
TABLE 135 WRIGHT MEDICAL GROUP N.V. - KEY FINANCIAL SUMMARY
TABLE 136 MEDELA AG - AT A GLANCE
TABLE 137 LOHMANN & RAUSCHER GMBH & CO. KG - AT A GLANCE
TABLE 138 NITTO DENKO CORPORATION - AT A GLANCE
TABLE 139 NITTO DENKO CORPORATION - KEY FINANCIAL SUMMARY
TABLE 140 WEIGAO GROUP CO. LTD. - AT A GLANCE
TABLE 141 WEIGAO GROUP CO., LTD. - KEY FINANCIAL SUMMARY

List of Figures
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 HONG KONG WOUND DRESSING MARKET SUMMARY
FIG 8 BARGAINING POWER OF BUYERS
FIG 9 BARGAINING POWER OF SUPPLIERS
FIG 10 INTENSITY OF RIVALRY
FIG 11 THREAT OF NEW ENTRANTS
FIG 12 THREAT OF SUBSTITUTES
FIG 13 INCIDENCE OF WOUNDS IN HONG KONG (2014-2030)
FIG 14 INCIDENCE OF WOUNDS IN HONG KONG, BY TYPE (2014-2030)
FIG 15 INCIDENCE OF ACUTE WOUNDS IN HONG KONG, BY TYPE (2014-2030)
FIG 16 INCIDENCE OF CHRONIC WOUNDS IN HONG KONG, BY TYPE (2014-2030)
FIG 17 HONG KONG WOUND DRESSING MARKET SNAPSHOT
FIG 18 HONG KONG WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2030)
FIG 19 HONG KONG ADVANCED WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2030)
FIG 20 HONG KONG TRADITIONAL WOUND DRESSING MARKET, BY TYPE, $’000 (2014-2030)
FIG 21 HONG KONG WOUND DRESSING MARKET, BY APPLICATION, $’000 (2014-2030)
FIG 22 HONG KONG WOUND DRESSING MARKET FOR CHRONIC WOUNDS, BY TYPE, $’000 (2014-2030)
FIG 23 HONG KONG WOUND DRESSING MARKET FOR ACUTE WOUNDS, BY TYPE, $’000 (2014-2030)
FIG 24 HONG KONG WOUND DRESSING MARKET, BY END USER, $’000 (2014-2030)
FIG 25 HONG KONG WOUND DRESSING MARKET IN HOSPITALS AND SPECIALTY CLINICS, BY TYPE, $’000 (2014-2030)
FIG 26 HONG KONG WOUND DRESSING MARKET, BY DISTRIBUTION CHANNEL, $’000 (2014-2030)
FIG 27 COLOPLAST A/S - REVENUE SPLIT BY BUSINESS AREA AND GEOGRAPHY (2019)
FIG 28 3M COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 29 PAUL HARTMANN AG - REVENUE SPLIT BY BUSINESS DIVISION AND GEOGRAPHY (2019)
FIG 30 MÖLNLYCKE HEALTH CARE AB - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 31 SMITH & NEPHEW PLC - REVENUE SPLIT BY PRODUCT FRANCHISE AND GEOGRAPHY (2019)
FIG 32 CONVATEC GROUP PLC - REVENUE SPLIT BY FRANCHISE AND GEOGRAPHY (2019)
FIG 33 B. BRAUN MELSUNGEN AG - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
FIG 34 BEIERSDORF AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 35 JOHNSON & JOHNSON - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 36 CARDINAL HEALTH INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 37 MEDTRONIC PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 38 INTEGRA LIFESCIENCES HOLDINGS CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 39 WRIGHT MEDICAL GROUP N.V. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 40 NITTO DENKO CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 41 WEIGAO GROUP CO., LTD. - REVENUE SPLIT BY PRINCIPLE PRODUCT AND GEOGRAPHY (2019)
Note: Product cover images may vary from those shown
3 of 4
  • Coloplast A/S
  • 3M Company
  • Paul Hartmann AG
  • Winner Medical Co. Ltd.
  • Mölnlycke Health Care AB
  • Smith & Nephew PLC
  • ConvaTec Group PLC
  • Allmed Medical Products Co. Ltd.
  • Zhende Medical Co. Ltd.
  • Wayson Medical Co. Ltd.
  • B. Braun Melsungen AG
  • BSN medical GmbH
  • Beiersdorf AG
  • Johnson & Johnson
  • Urgo Medical
  • Cardinal Health Inc.
  • Medtronic plc
  • Integra LifeSciences Holdings Corporation
  • Wright Medical Group N.V.
  • Medela AG
  • Lohmann & Rauscher GmbH & Co. KG
  • Nitto Denko Corporation
  • Weigao Group Co. Ltd.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll